Pediatric Ependymoma: Biological Perspectives

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Cancer Research

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-08-0584PMID 19531565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Childhood Cancer

  2020cited by this paper
• Real‐time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12‐q13

  2008cited by this paper
• Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.

  2008cited by this paper
• Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma

  2008cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.

  2008cited by this paper
• Efficient tumour formation by single human melanoma cells

  2008cited by this paper
• Histopathological grading of intracranial pediatric ependymomas

  2008cited by this paper
• Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.

  2008cited by this paper
• The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors

  2008cited by this paper
• O6- Methylguanine-DNA-Methyltransferase in Recurring Anaplastic Ependymomas: PCR and Immunohistochemistry

  2008cited by this paper
• Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas

  2008cited by this paper
• Cancer stem cells in radiation resistance.

  2007cited by this paper
• Brain and Spinal Tumors of Childhood

  2007cited by this paper
• Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007cited by this paper
• Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.

  2007cited by this paper
• Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival

  2007cited by this paper
• Short telomeres limit tumor progression in vivo by inducing senescence.

  2007cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.

  2006cited by this paper
• APC and CTNNB1 mutations are rare in sporadic ependymomas.

  2006cited by this paper
• Chromosomal imbalances in clear cell ependymomas

  2006cited by this paper
• The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas.

  2006cited by this paper
• Stem cells of ependymoma

  2006cited by this paper
• Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths

  2006cited by this paper
• Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial Ependymoma

  2006cited by this paper
• Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

  2006cited by this paper
• Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas

  2006cited by this paper
• Predicting which children are at risk for ependymoma relapse

  2006cited by this paper
• Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.

  2006cited by this paper
• Brain tumour stem cells

  2006cited by this paper
• p53 pathway dysfunction in primary childhood ependymomas

  2006cited by this paper
• Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival

  2005cited by this paper
• Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics.

  2005cited by this paper
• Childhood solid tumours: a developmental disorder

  2005cited by this paper
• Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence

  2005cited by this paper
• Localization of a putative low‐penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling‐path genomic microarray

  2005cited by this paper
• Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.

  2005cited by this paper
• Alterations of protein 4.1 family members in ependymomas: a study of 84 cases

  2005cited by this paper
• Adult Ependymal Cells Are Postmitotic and Are Derived from Radial Glial Cells during Embryogenesis

  2005cited by this paper
• Jagged1 signals in the postnatal subventricular zone are required for neural stem cell self‐renewal

  2005cited by this paper
• Radial glia cells are candidate stem cells of ependymoma.

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Supratentorial extraventricular ependymal neoplasms

  2005cited by this paper
• Ependymoma: New Therapeutic Approaches Including Radiation and Chemotherapy

  2005cited by this paper
• Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.

  2005cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Analysis of HIC‐1 methylation and transcription in human ependymomas

  2004cited by this paper
• Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.

  2004cited by this paper
• Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study

  2004cited by this paper
• A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma

  2004cited by this paper
• The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era

  2004cited by this paper
• Inverse Correlation between Genetic Aberrations and Malignancy Grade in Ependymal Tumors: A Paradox?

  2004cited by this paper
• Prognostic Value of Immunoexpression of the Chemoresistance-related Proteins in Ependymomas: an Analysis of 76 Cases

  2004cited by this paper
• Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours

  2004cited by this paper
• Proliferation- and Apoptosis-related Proteins in Intracranial Ependymomas: An Immunohistochemical Analysis

  2004cited by this paper
• Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.

  2004cited by this paper
• The extracellular matrix glycoprotein Tenascin‐C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet‐derived growth factor

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Telomere maintenance in childhood primitive neuroectodermal brain tumors.

  2004cited by this paper
• 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases

  2004cited by this paper
• Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma.

  2004cited by this paper
• Distinct Populations of Forebrain Neural Stem and Progenitor Cells Can Be Isolated Using Side-Population Analysis

  2003cited by this paper
• Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.

  2003cited by this paper
• A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor

  2003cited by this paper
• Loss of chromosome 22 and proliferative potential in ependymomas.

  2003cited by this paper
• CDKN2A, CDKN2B and p14 ARF are frequently and differentially methylated in ependymal tumours

  2003cited by this paper
• Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.

  2003cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• Radial glia diversity: A matter of cell fate

  2003cited by this paper
• Expression of mos in ependymal gliomas.

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade

  2003cited by this paper
• Human ependymomas reveal frequent deletions on chromosomes 6 and 9

  2003cited by this paper
• Pediatric Intracranial Ependymomas: Prognostic Relevance of Histological, Immunohistochemical, and Flow Cytometric Factors

  2003cited by this paper
• Immunohistochemical Markers for Prognosis of Ependymal Neoplasms

  2002cited by this paper
• Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.

  2002cited by this paper
• Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells.

  2002cited by this paper
• Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.

  2002cited by this paper
• Genetic abnormalities detected in ependymomas by comparative genomic hybridisation

  2002cited by this paper
• Postoperative Radiotherapy for Intracranial Ependymoma: Analysis of Prognostic Factors and Patterns of Failure

  2002cited by this paper
• Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH

  2002cited by this paper
• ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.

  2002cited by this paper
• Complex cytogenetic abnormalities including telomeric associations and MEN1 mutation in a pediatric ependymoma.

  2002cited by this paper
• Differential Involvement of Protein 4.1 Family Members DAL-1 and NF2 in Intracranial and Intraspinal Ependymomas

  2002cited by this paper
• Loss of heterozygosity on chromosome 22 in human ependymomas

  2002cited by this paper
• Intracranial Ependymomas: An Analysis of Prognostic Factors and Patterns of Failure

  2002cited by this paper
• Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

  2002cited by this paper
• Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.

  2001cited by this paper
• Characterization of CNS precursor subtypes and radial glia.

  2001cited by this paper
• Telomere dysfunction increases mutation rate and genomic instability.

  2001cited by this paper
• Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma

  2001cited by this paper
• Molecular genetic alterations on chromosomes 11 and 22 in ependymomas

  2001cited by this paper
• Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

  2001cited by this paper
• Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.

  2001cited by this paper
• Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1

  2001cited by this paper
• A review of the cytogenetics of 58 pediatric brain tumors.

  2001cited by this paper

• The immunopeptidomic landscape of ependymomas provides actionable antigens for T-cell-based immunotherapy

  2025cites this paper
• Survival Patterns and Mortality Causes in Patients with Invasive Ependymoma: A Retrospective Cohort Analysis from 2000 to 2019

  2025cites this paper
• Recurrence patterns in pediatric intracranial ependymal neoplasm: a systematic imaging work-up

  2025cites this paper
• Identification of Hub Genes in Ependymoma Through Weighted Gene Co-Expression Network Analysis

  2025cites this paper
• Ependymoma from Benign to Highly Aggressive Diseases: A Review.

  2024cites this paper
• Clinicopathological profile of ependymomas with special reference to survival data - Experiences of a tertiary care center'.

  2024cites this paper
• Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature

  2024influential citation
• An Update on Emergent Nano-Therapeutic Strategies against Pediatric Brain Tumors

  2024cites this paper
• Noise suppression of proton magnetic resonance spectroscopy improves paediatric brain tumour classification

  2024cites this paper
• Pediatric Neuroglial Tumors: A Review of Ependymoma and Dysembryoplastic Neuroepithelial Tumor.

  2024cites this paper
• Impact of Molecular Subgroups on Prognosis and Survival Outcomes in Posterior Fossa Ependymomas: A Retrospective Study of 412 Cases

  2024cites this paper
• Overcoming the challenge of a thin skull in a 2-year-old patient undergoing laser interstitial thermal therapy using an individualized stereotactic platform: illustrative case

  2024cites this paper
• CAR T-cells to treat brain tumors.

  2023cites this paper
• In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma

  2023cites this paper
• Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural Metastases

  2023cites this paper
• A Pediatric Case of Extraneural Subcutaneous Metastasis of Ependymoma.

  2023cites this paper
• Comprehensive Review of Primary Posterior Fossa Tumors in Children

  2023cites this paper
• The biology of ependymomas and emerging novel therapies

  2022cites this paper
• Pediatric Brain Tumors in the Molecular Era: Updates for the Radiologist.

  2022cites this paper
• Advances on Epigenetic Drugs for Pediatric Brain Tumors

  2022cites this paper
• A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy

  2022cites this paper
• Posterior fossa ependymoma in neurodevelopmental syndrome caused by a de novo germline pathogenic POLR2A variant

  2022cites this paper
• Epigenetic mechanisms in paediatric brain tumours: regulators lose control.

  2022cites this paper
• Driver mutations in ADGRL3 are involved in the evolution of ependymoma

  2022cites this paper
• Gross Total Resection of Childhood Intracranial Ependymoma is a Critically Important Factor in Survival

  2021cites this paper
• Epidemiology and prognostic factors of pediatric brain tumor survival in the US: Evidence from four decades of population data.

  2021cites this paper
• The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study

  2021cites this paper
• Pediatric ependymoma: an overview of a complex disease

  2021influential citation
• Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies

  2021influential citation
• Pathology and Molecular Pathology of Ependymoma

  2021cites this paper
• Citation analysis of the most influential ependymoma research articles illustrates improved knowledge of the molecular biology of ependymoma

  2021cites this paper
• EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma

  2021cites this paper
• Radiomic Signatures of Posterior Fossa Ependymoma: Molecular Subgroups and Risk Profiles.

  2021cites this paper
• Sequential Orbitrap Secondary Ion Mass Spectrometry and Liquid Extraction Surface Analysis-Tandem Mass Spectrometry-Based Metabolomics for Prediction of Brain Tumor Relapse from Sample-Limited Primary Tissue Archives.

  2021cites this paper
• BLBP Is Both a Marker for Poor Prognosis and a Potential Therapeutic Target in Paediatric Ependymoma

  2021cites this paper
• Childhood Malignant Brain Tumors: Balancing the Bench and Bedside

  2021cites this paper
• Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma

  2020cites this paper
• Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome

  2020cites this paper
• Sequential 3D OrbiSIMS and LESA-MS/MS-based metabolomics for prediction of brain tumor relapse from sample-limited primary tissue archives

  2020cites this paper
• NF-κB Subunits p50 and RelA Contribute to Oncogenesis in a Mouse Model of ST-EPN

  2020cites this paper
• Metabolic profiles as putative predictors of relapse in pediatric brain tumour using direct surface and imaging mass spectrometry

  2020cites this paper
• Molecular characterization of histopathological ependymoma variants

  2020cites this paper
• Novel Insights Into Epigenetic Reprogramming and Destabilization of Pericentromeric Heterochromatin in Cancer

  2020cites this paper
• Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma

  2020cites this paper
• Author Correction: YAP1/TAZ drives ependymoma-like tumour formation in mice

  2020cites this paper
• Cerebral Gliomas

  2020cites this paper
• YAP1/TAZ drives ependymoma-like tumour formation in mice

  2020cites this paper
• Familial Cerebral Cavernous Malformation Syndrome with Concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence?

  2020cites this paper
• Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma

  2020cites this paper
• Intracranial ependymomas: molecular insights and translation to treatment

  2020cites this paper
• Is H3K27me3 status really a strong prognostic indicator for pediatric posterior fossa ependymomas? A single surgeon, single center experience

  2020cites this paper
• The Role of Histone Modifying Enzyme SUV 420 H 2 in Pediatric Ependymoma

  2019cites this paper
• Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China

  2019cites this paper
• Global Reduction of H 3 K 4 me 3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas 1

  2019cites this paper
• Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas

  2019cites this paper
• Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing

  2019cites this paper
• Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.

  2019cites this paper
• Ependymal Tumors

  2019cites this paper
• Parkinsonism caused by Intracranial ependymoma: A rare case report and literature review

  2019cites this paper
• Identification of biomarkers and construction of a microRNA-mRNA regulatory network for ependymoma using integrated bioinformatics analysis

  2019cites this paper
• EZHIP / CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma.

  2019cites this paper
• Expression and Clinical Significance of Translation Regulatory Long Non-Coding RNA 1 (TRERNA1) in Ependymomas

  2019cites this paper
• Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors

  2019cites this paper
• The value of high‐dose radiotherapy in intracranial ependymoma

  2019cites this paper
• Ependymoma in the Children

  2019cites this paper
• A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma

  2019cites this paper
• Pediatric Brain Tumors.

  2018cites this paper
• Impact of radiation therapy and extent of resection for ependymoma in young children: A population‐based study

  2018cites this paper
• Ependymoma

  2018cites this paper
• PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population

  2018cites this paper
• Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology

  2018cites this paper
• Pediatric Supratentorial Ependymoma: Surgical, Clinical, and Molecular Analysis.

  2018cites this paper
• Pediatric ependymoma: current treatment and newer therapeutic insights.

  2018cites this paper
• Transcriptional co-expression regulatory network analysis for Snail and Slug identifies IL1R1, an inflammatory cytokine receptor, to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas

  2018cites this paper
• Molecular Biology of Human Brain Tumors

  2017cites this paper
• Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.

  2017cites this paper
• Molecular mechanisms and therapeutic targets in pediatric brain tumors

  2017cites this paper
• The Molecular Feature of HOX Gene Family in the Intramedullary Spinal Tumors

  2017cites this paper
• Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood

  2017cites this paper
• Prognostic relevance of miR‐124‐3p and its target TP53INP1 in pediatric ependymoma

  2017cites this paper
• Pediatric Thalamic Gliomas: An Updated Review.

  2017cites this paper
• Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain

  2017cites this paper
• Pediatric Thalamic Gliomas

  2017cites this paper
• p16 Loss and E2F/cell cycle deregulation in infant posterior fossa ependymoma

  2017cites this paper
• Supratentorial Parenchymal Ependymomas in Children: Experience with 14 Patients at a Single Institute.

  2017cites this paper
• PET/MR in Children

  2016cites this paper
• Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma

  2016cites this paper
• Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches

  2016cites this paper
• The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective

  2016cites this paper
• Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.

  2016cites this paper
• Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients

  2016cites this paper
• Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases

  2016cites this paper
• Multiomics approach showing genome-wide copy number alterations and differential gene expression in different types of North-Indian pediatric brain tumors.

  2016cites this paper
• Treatment and survival of supratentorial and posterior fossa ependymomas in adults.

  2016cites this paper
• Evaluation of chromosome 1q gain in intracranial ependymomas

  2016cites this paper
• Pediatric Ependymoma

  2016influential citation
• [Pediatric ependymomas: Current diagnosis and therapy].

  2016cites this paper
• Genomic characterization of recurrent high-grade astroblastoma.

  2016cites this paper
• Microsurgical management of pediatric ependymomas of the fourth ventricle via the trans-cerebellomedullary fissure approach: A review of 26 cases.

  2016cites this paper
• Common Pediatric Central Nervous System Tumors: Histology and Molecular Biology

  2016cites this paper